An Enhanced Therapeutic Interfering Particle Against Influenza Virus Therapeutics | Biologics | Infectious
A More Stable and Efficient Retroviral Gene Delivery Vector This technology is a viral vector based on the murine leukemia virus (MLV), which has been favored for clinical gene therapy due to its preferential infectivity of human cell types. The original vecto… Therapeutics | Drug Delivery, Stem Cells, Genomics/Proteomics | Human Systems | Disease Type | None of These
New Drugs for Malarial and Bacterial Infections Therapeutics | Antibiotic | All of These | Disease Type | Oncologic
Supramolecular Assembly for Non-Viral Gene Delivery Therapeutics | Human Systems | Disease Type | None of These
Gene Cluster Capable of Enabling the Biosynthesis of the Antimicrobial Compound, Rhizocticin In Bacillus subtilis Therapeutics | Antifungal | Human Systems | Disease Type | Infectious
Enhancement of Immune Response to Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Interferon Alpha Therapeutics | Vaccines | Disease Type | Infectious
Biosynthesis of Lantibiotics: In vitro semi-synthetic production methods for generation of industrial antibiotic, Lacticin 481 Therapeutics | Antibiotic | Human Systems | Disease Type | None of These
Compounds That Selectively Induce Cancerous Cell Death in the G1 Phase of the Cell Cycle Therapeutics | Human Systems | Disease Type | Oncologic
Pharmaceutical Compounds and Pathways from Actinobacteria Therapeutics | All of These | Disease Type | All of These